Research & Development (R&D) is actively being pursued in regenerative medicine using iPS, ES, and mesenchymal stem cells, pushing up the need for cryogenic shipping of biological specimens and samples, according to The Gas Review.
To ship at -150°C or less requires liquid nitrogen (N2) and cryopreservation containers, but current shipping quantities are too small to create markets of any size. However, the pharmaceutical industry is about to enter the age of the revolutionary change from low-molecular pharmaceuticals to bio-pharmaceuticals, and distribution of regenerative medical products is set to most surely increase in the near future. This has drawn a lot of interest in cryogenic shipping not only from industrial gas companies, but also from distributors.
What’s more, the rapid increase in demand for dry shippers, one type of cryopreservation containers, cannot be overlooked. There is no doubt that regenerative medicine will increase the demand for carbon dioxide gas and nitrogen to cultivate and store cells, but it seems that it will be cryogenic shipping using dry shippers that will drive this young market.
Liquid N2 feeder installed at distribution centres
... to continue reading you must be subscribed
